National Cancer Institute NCI Cancer Bulletin: A Trusted Source for Cancer Research News
April 21, 2009 • Volume 6 / Number 8

The information and links on this page are no longer being updated and are provided for reference purposes only.


Logo for the American Association for Cancer Research 100th Annual Meeting 2009 Ovarian Cancer Markers Validated for Early Detection

A rigorous validation study of more than 50 potential markers for detecting early signs of ovarian cancer in blood has found that the most accurate marker is CA-125, a protein that is already routinely monitored in women with the disease. Panels of markers tested in the study offered, at best, only marginal improvements in the ability to detect the disease over CA-125 alone. Read more > >


Director's Update: The Extraordinary Challenges and Opportunities Facing Cancer Research

The Director’s Update for this issue is an abridged version of the remarks delivered by NCI Director Dr. John E. Niederhuber on Monday, April 20, at the 100th Annual Meeting of the American Association for Cancer Research in Denver. Read more > >

Guest Commentary by Dr. Margaret Foti: A Century of Progress, A Future of Promise

The chief executive officer of the American Association for Cancer Research shares her thoughts about past accomplishments and future efforts in cancer research Read more > >


Special Issue on Bioinformatics

Don’t miss our May 5 special issue on bioinformatics, which will highlight recent meetings, progress on electronic health records, research advances, and resources for those who are looking to collaborate or secure project funding.

NCI Cancer Bulletin special issues are some of the most popular among our readers. Past special issues have focused on childhood cancers, personalized drug development, and cancer imaging.



  • NIH Update

    • New Stem Cell Guidelines Proposed by NIH

    FDA Update

    • GSK Seeks Approval for HPV Vaccine


    • Fraumeni Receives AACR Lifetime Achievement Award
    • Barker Receives AACR Margaret Foti Award
    • NCI Chief Operating Officer Lawrence Ray Retiring
    • NCI Lecture Series Features Dr. Julie Overbaugh Update

    • Streamlines Clinical Trials Search Process
    • New Resources on Cancer Health Disparities Research Available

The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information about cancer, call 1-800-4-CANCER or visit

NCI Cancer Bulletin staff can be reached at

Next Section >